Abstract
Cancer cells typically display altered glucose metabolism characterized by a preference of aerobic glycolysis, known as the Warburg effect, which facilitates cell proliferation. Hypoxia-inducible factor (HIF) and oncoprotein Myc are two prominent transcription factors that drive glycolysis. Previously, we reported that the estrogen-related receptors (ERRs) act as cofactors of HIF and enhance HIF-dependent transcription of glycolytic genes under hypoxia. ERRs are orphan nuclear receptors and key regulators of energy metabolism by orchestrating mitochondrial biogenesis, fatty acid oxidation (FAO) and oxidative phosphorylation. Here, we show that ERRs also stimulate glycolysis under normoxia. ERRs directly bind to and activate promoters of many genes encoding glycolytic enzymes, and the ERR-binding sites in such promoters are essential for ERR-mediated transcriptional activation. ERRs interact with Myc, and the two factors synergistically activate transcription of glycolytic genes. Furthermore, overexpression of ERRs increases glycolytic gene expression and lactate production. Conversely, depletion of ERRs in cancer cells reduces expression of glycolytic genes and glucose uptake, resulting in decreased aerobic glycolysis and cell growth. Taken together, these results suggest that ERRs are important transcriptional activators of the glycolytic pathway and contribute to the Warburg effect in cancer cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Koppenol WH, Bounds PL, Dang CV . Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer 2011; 11: 325–337.
Vander Heiden MG, Cantley LC, Thompson CB . Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324: 1029–1033.
Locasale JW, Grassian AR, Melman T, Lyssiotis CA, Mattaini KR, Bass AJ et al. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat Genet 2011; 43: 869–874.
Possemato R, Marks KM, Shaul YD, Pacold ME, Kim D, Birsoy K et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 2011; 476: 346–350.
Kroemer G, Pouyssegur J . Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 2008; 13: 472–482.
Hsu PP, Sabatini DM . Cancer cell metabolism: Warburg and beyond. Cell 2008; 134: 703–707.
Dang CV, Kim JW, Gao P, Yustein J . The interplay between MYC and HIF in cancer. Nat Rev Cancer 2008; 8: 51–56.
Tennant DA, Durán RV, Gottlieb E . Targeting metabolic transformation for cancer therapy. Nat Rev Cancer 2010; 10: 267–277.
Levine AJ, Puzio-Kuter AM . The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 2010; 330: 1340–1344.
Semenza GL . Regulation of cancer cell metabolism by hypoxia-inducible factor 1. Semin Cancer Biol 2009; 19: 12–16.
Kim JW, Tchernyshyov I, Semenza GL, Dang CV . HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 2006; 3: 177–185.
Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC . HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 2006; 3: 187–197.
Semenza GL . Hypoxia-inducible factor 1: regulator of mitochondrial metabolism and mediator of ischemic preconditioning. Biochem Biophys Acta 2011; 1813: 1263–1268.
Kim JW, Zeller KI, Wang Y, Jegga AG, Aronow BJ, O'Donnell KA et al. Evaluation of myc E-box phylogenetic footprints in glycolytic genes by chromatin immunoprecipitation assays. Mol Cell Biol 2004; 24: 5923–5936.
Ao A, Wang H, Kamarajugadda S, Lu J . Involvement of estrogen-related receptors in transcriptional response to hypoxia and growth of solid tumors. Proc Natl Acad Sci USA 2008; 105: 7821–7826.
Giguère V . Transcriptional control of energy homeostasis by the estrogen-related receptors. Endocr Rev 2008; 29: 677–696.
Hock MB, Kralli A . Transcriptional control of mitochondrial biogenesis and function. Annu Rev Physiol 2009; 71: 177–203.
Hue L, Taegtmeyer H . The Randle cycle revisited: a new head for an old hat. Am J Physiol Endocrinol Metab 2009; 297: E578–E591.
Wende AR, Huss JM, Schaeffer PJ, Giguère V, Kelly DP . PGC-1alpha coactivates PDK4 gene expression via the orphan nuclear receptor ERRalpha: a mechanism for transcriptional control of muscle glucose metabolism. Mol Cell Biol 2005; 25: 10684–10694.
Zhang Y, Ma K, Sadana P, Chowdhury F, Gaillard S, Wang F et al. Estrogen-related receptors stimulate pyruvate dehydrogenase kinase isoform 4 gene expression. J Biol Chem 2006; 281: 39897–39906.
Araki M, Motojima K . Identification of ERRalpha as a specific partner of PGC-1alpha for the activation of PDK4 gene expression in muscle. FEBS J 2006; 273: 1669–1680.
Dufour BJ, Wilson JM, Huss DP, Kelly WA, Alaynick M, Downes RM et al. Genone-wide orchestration of cardiac functions by orphan nucler receptors ERRα and γ. Cell Metab 2007; 5: 345–356.
Deblois JA, Hall MC, Perry J, Laganière M, Ghahremani M, Park M et al. Genome-wide identification of direct target genes implicates estrogen-related receptor α as a determinant of breast cancer heterogeneity. Cancer Res 2009; 69: 6149–6157.
Charest-Marcotte CR, Dufour BJ, Wilson AM, Tremblay LJ, Eichner DH, Arlow VK et al. The homeobox protein Prox1 is a negative modulator of ERRα/PGC-1α bioenergetic functions. Genes Dev 2010; 24: 537–542.
Tennessen JM, Baker KD, Lam G, Evans J, Thummel CS . The Drosophila estrogen-related receptor directs a metabolic switch that supports developmental growth. Cell Metab 2011; 13: 139–148.
Ariazi EA, Jordan VC . Estrogen-related receptors as emerging targets in cancer and metabolic disorders. Curr Top Med Chem 2006; 6: 203–215.
Chang CY, Kazmin D, Jasper JS, Kunder R, Zuercher WJ, McDonnell DP . The metabolic regulator ERRα, a downstream target of HER2/IGF-1R, as a therapeutic target in breast cancer. Cancer Cell 2011; 20: 500–510.
Stein RA, Chang CY, Kazmin DA, Way J, Schroeder T, Wergin M et al. Estrogen-related receptor α is critical for the growth of estrogen receptor-negative breast cancer. Cancer Res 2008; 68: 8805–8812.
Wu M, Neilson A, Swift AL, Moran R, Tamagnine J, Parslow D et al. Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. Am J Physiol Cell Physiol 2007; 292: C125–C136.
Hardie DG . AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes Dev 2011; 25: 1895–1908.
Jose C, Bellance N, Rossignol R . Choosing between glycolysis and oxidative phosphorylation: a tumor's dilemma? Biochem Biophys Acta 2011; 1807: 552–561.
Eichner LJ, Perry MC, Dufour CR, Bertos N, Park M, St-Pierre J et al. mir-378* mediates metabolic shift in breast cancer cells via the PGC-1β/ERRγ transcriptional pathway. Cell Metab 2010; 12: 352–361.
Li F, Wang Y, Zeller KI, Potter JJ, Wonsey DR, O'Donnell KA et al. Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis. Mol Cell Biol 2005; 25: 6225–6234.
Dang CV, Le A, Gao P . MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin Cancer Res 2009; 15: 6479–6483.
Acknowledgements
This work was supported by grants from the National Cancer Institute (R01CA137021) and Florida Bankhead-Coley Cancer Research Program (09BN-12-23092 and 2BT01).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Oncogene website
Supplementary information
Rights and permissions
About this article
Cite this article
Cai, Q., Lin, T., Kamarajugadda, S. et al. Regulation of glycolysis and the Warburg effect by estrogen-related receptors. Oncogene 32, 2079–2086 (2013). https://doi.org/10.1038/onc.2012.221
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2012.221
Keywords
This article is cited by
-
ERRα: unraveling its role as a key player in cell migration
Oncogene (2024)
-
Dihydroartemisinin suppresses glioma growth by repressing ERRα-mediated mitochondrial biogenesis
Molecular and Cellular Biochemistry (2023)
-
ERRα coordinates actin and focal adhesion dynamics
Cancer Gene Therapy (2022)
-
ERRα expression in ovarian cancer and promotes ovarian cancer cells migration in vitro
Archives of Gynecology and Obstetrics (2022)
-
Hyper‐metabolic B cells in the spleens of old mice make antibodies with autoimmune specificities
Immunity & Ageing (2021)